Symbol :

Current Price : $37.19


52 Week Low
$31.83
52 Week High
$49.45
 

GILD Share Performance

Period GILD Compare to S&P
YTD -13.08 % -21.86 %
4 Weeks -0.50 % -3.81 %
12 Weeks 8.82 % -1.25 %
    • GILD - Key Data

    • Shares Outstanding: 811M
    • Market Cap: $30.53B
    • Avg Volume: 8427539
    • P/E Ratio: 10.720
    • PEG Ratio: 0.750
    • Split: On 6/25/2007 GILD split by factor of 2.000
    • GILD - Dividend

    • Ex-Dividend Date: N/A
    • Annual Dividend: N/A
    • Current Dividend Yield: N/A
    • Dividend Paid (3 months): N/A
    • Indicated Dividend: N/A
    • GILD - Earnings

    • EPS Growth in Last Quarter: 4.94 %
    • EPS Growth in Last Year: 14.86 %
    • Sales Growth in Last Quarter: 0.54 %
    • Sales Growth in Last Year: 7.56 %
    • Last Earnings Date: 9/30/2010
    • Next Earnings Date(Expected): 1/25/2011
    • Mean EPS (Next Qtr): $0.88
    • Mean EPS (Year): $3.50
    • Mean Estimate(Long Term): $14.24
    • P/E Ratio(Based on EPS estimate): 10.740
    • Number of Estimates: 12

Sector: Medical       Industry: MED-BIOMED/GENE     
GILEAD SCI(NSDQ:GILD)

Profile
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective.
A : Strong Buy B : Buy C : Hold D : Sell F : Avoid

Alpha Rank:


Trade GILD now with
GILD - Fundamental Rank :

    No note

GILD - Performance Rank :

    No note

GILD - Technical Rank :

    No note

 

Sponsors

 

GILD Sector Analysis

GILD Sector Chart
 

GILD Analyst Ratings

GILD Analyst Chart

GILD Quarterly Sales Estimates

GILD Quarterly Estimates Chart
Qtr EndingHigh EstimateLow EstimateMean EstimateStandard DeviationLatest Estimate
09-201019951886.061928.39929.73110/15/2010
12-2010217818891982.49257.78612/5/2022
03-20112130.51975.7372034.0641.72112/5/2022
06-20112096.42010.12045.33128.47912/5/2022
09-20112163.862031.1172090.26443.36212/5/2022
12-20112225.692065.0092142.86854.64312/5/2022

GILD Yearly Sales Estimates

GILD Yearly Sales Estimates
Estimate YearHigh EstimateLow EstimateMean EstimateStandard DeviationLatest Estimate
2010818574237914.475119.10712/6/2021
20118734.18089.4458400.197161.38412/6/2021
20129822.1828480.59095.914345.58212/6/2021
201310768.993319957.35448.43712/6/2021
2014120819710.0510876.87844.37312/6/2021
201513076.19968.57611981.5841141.47912/6/2021
201611556.589991.61910774.0991106.59412/6/2021

Quarterly Earnings Estimates for GILD

GILD Quarterly Estimates Chart
Quarter
12-2010
03-2011
Mean Estimate
$0.88 $0.92
Number of Estimates
12 8
High Estimate
$0.92 $0.99
Low Estimate
$0.83 $0.84
EPS Last Year
$0.90 $0.95
%Growth
-2.00 % -3.00 %

Yearly Earnings Estimates for GILD

GILD Yearly Estimates Chart
Year
2010
2011
Mean Estimate
$3.50 $3.86
Number of Estimate
12 12
High Estimate
$3.57 $0.00
Low Estimate
$3.44 $4.18
EPS Last Year
$3.50 2.9200
%Growth
10.00 % 20.00 %